http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0286278-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C307-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C215-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C307-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C209-00
filingDate 1988-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1991-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1991-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0286278-B1
titleOfInvention Indanamine derivatives useful as antiarrhythmic agents
abstract Compounds of the formula:- <CHEM> and their salts, wherein each R, which is the same, is -NHSO2(C1-C4 alkyl),-NH2 or -NO2; X is 0 or a direct link; R<1> is H, C1-C4 alkyl, C1-C4 alkoxy or halo; and n is 1 or 2, with the proviso that when X is 0, n is 2. The compounds of the formula (A) in which each R is -NHSO2(C1-C4 alkyl) are antiarrhythmic agents. The compounds in which R is -NH2 or -NO2 are synthetic intermediates.
priorityDate 1987-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466655948
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22772359
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468400011
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421296724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426253860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466435775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14835237

Total number of triples: 38.